Scott M. Paler Elected to DeWitt’s Executive Committee
DeWitt LLP law firm has elected Scott M. Paler to its Executive Committee effective April 14, 2021. The role of DeWitt’s Executive Committee is to oversee and hold accountable the firm’s management team, including the President and Managing Partner. This includes providing feedback and opinions about the management team’s sustainability and growth strategies, operational plans, budgets, financial performance, and risk assessments.
Paler is a partner at DeWitt LLP. He serves as chair of the firm’s Background Screening Practice Group, past-chair of the firm’s Employment Practice Group, and an active member of DeWitt’s Litigation Practice Group. He has developed a niche expertise in background screening and has advised more than 100 background screening companies on compliance and business issues. In addition to working with background screening companies, Paler has assisted employers nationwide in creating and administering sound, legally compliant background screening programs. Paler earned a JD, cum laude, from University of Wisconsin Law School and a BA, with distinction, from the University of Wisconsin, Phi Beta Kappa. He is admitted to practice in Illinois and Wisconsin and is a member of the Professional Background Screening Association (PBSA).
DeWitt LLP was founded in 1903 and is one of the 10 largest law firms based in Wisconsin, with an additional presence in Minnesota. It has more than 120 attorneys practicing in Green Bay, Madison and Metropolitan Milwaukee, Wisconsin, and Minneapolis, Minnesota, and has the experience to service clients of all scopes and sizes. The firm is known for its work in a variety of legal areas including intellectual property, patents, trademarks and copyright law, construction litigation, corporate law, employment, environmental, employee benefits, estate planning, family business, family law, government relations, health care, litigation, real estate, and tax law.
More Alumni Notes
Leah Hunter ’05 has joined the U.S. Food and Drug Administration (FDA) as associate commissioner for external affairs, where she oversees agency-wide communications activities regarding the FDA’s public health and regulatory activities.